The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients

This study evaluates the impact of a medication therapy management (MTM) model — a structured program where pharmacists closely review and optimize a patient's medication regimen — on the safety and effectiveness of anticoagulant (blood-clot preventing) treatment in patients with colorectal cancer who have also developed a blood clot in their veins (venous thromboembolism, or VTE). Cancer patients on blood thinners are at heightened risk of both clotting and bleeding, and pharmacist-led management may help improve outcomes. **You may be eligible if...** - You have histologically confirmed colorectal cancer - You have been diagnosed with a VTE (blood clot) and have been treated with an anticoagulant for at least 3 months - You are currently receiving active anticoagulant treatment **You may NOT be eligible if...** - You are not on active anticoagulant therapy at the time of the study Talk to your doctor to see if this trial is right for you.